Development and Clinical validity of a novel blood-based molecular biomarker for sub-clinical acute rejection following kidney transplant

American Journal of Transplantation First published: 09 July 2018 https://doi.org/10.1111/ajt.15011

John J. Friedewald1, Sunil M. Kurian, Raymond L. Heilman, Thomas C. Whisenant, EmilioD. Poggio, Christopher Marsh, Prabhakar Baliga MD, Jonah Odim, Merideth M. Brown, David N. Ikle, Brian D. Armstrong, jane I. charette, Susan S. Brietigam, Nedjema Sustento-Reodica, Lihui Zhao, Manoj Kandpal, Daniel R. Salomon†, and Michael M. Abecassis*(ORCID 0000-0001-9333-463X), for the Clinical Trials in Organ Transplantation08 (CTOT-08)